If approved, it will be the first GLP-1 to treat MASH, and an FDA decision is anticipated by the third quarter of 2025
With gradual weight loss and attention to warning signs, most patients can continue treatment safely
During this visit, your provider typically reviews your past and current weight, body mass index, blood pressure, cholesterol levels, and blood sugar history
The brand's own FAQ states that "certain medications, specific formulations, or fulfillment options may vary" by state due to pharmacy licensing, a point covered in more detail in the pharmacy section below
It's alarming, but I try to focus on the positive changes in my health." " My doctor reassured me that the hair loss is temporary